Tucson Symposium 2019

AGENDA

 Subject to change
Tuesday, April 9, 2019
 
 8:00 am Tucson Symposium Welcome and Opening Remarks 
 8:15 am Tom Grogan Honorary Keynote Lecture
 Presentation title to be announced
 Thomas Gajewski, MD, PhD (invited)
University of Chicago
Chicago, Illinois
Session 1
New Combinations for Personalizing Immunotherapy and Targeting Resistance
 8:55 am Session Introduction
 9:00 am Biomarkers for Personalized Immunotherapy
 David Rimm, MD, PhD (confirmed)
Yale University
New Haven, Connecticut
 9:20 am
Using Science to Guide Rational Combinations for Immunotherapy
Roy Herbst, MD, PhD (invited)
Yale Cancer Center
New Haven, Connecticut
 9:40 am Presentation title to be announced
 Speaker to be invited
10:00 am
Panel Discussion | Q&A | Session Close
  
10:30 am Break
 
Session 2
Informatics and Transforming Technologies

10:45 am Session Introduction
10:50 am
Presentation title to be announced
 Speaker to be invited
11:10 am Artificial Intelligence for Immuno-oncology Pathology:
From Discovery to AI-powered Companion Diagnostics

Andrew Beck, MD, PhD (confirmed)
PathAI
Cambridge, Massachusetts
11:30 am Opportunities and Challenges Adopting Digital Pathology for Primary Diagnosis Workflow



Anil Parwani, MD. PhD, MBA (invited) The Ohio State University
Columbus, Ohio
11:50 am Panel Discussion | Q&A | Session Close
  
12:20 pm Lunch
  
 1:30 pm Poster Session
 
Session 3 
New Frontiers in Colorectal Cancer

 3:00 pm Session Introduction
 3:05 pm Immunotherapy for MSI Metastatic Colorectal Cancer: Going Beyond MSI for Immunotherapy in Metastatic Colorectal Cancer
Thierry Andre, MD (invited)
Hôpital Saint-Antoine
Paris, France
 3:25 pm A Pathologist Perspective: Immunotherapy for MSI Metastatic Colorectal Cancer
Magali Svrcek, MD, PhD (invited)
Hôpital Saint-Antoine
Paris, France
 3:45 pm Targeted Therapies in Colorectal Cancer
 Scott Kopetz, MD, PhD (invited)
MDAnderson Cancer Center Houston, Texas
 4:05 pm
Implications of MSI and BRAF Status for Treatment of Non-metastatic Colon Cancer: Immune Markers and Immunotherapy
 Frank Sinicrope, MD (invited)
Mayo Clinic
Rochester, Minnesota
 4:25 pm Panel Discussion | Q&A | Session Close
 4:55 pm Close of day one 
  
 6:30 pm Dinner at El Conquistador
Program to be announced 
Wednesday, April 10, 2019
 8:00 am Welcome
 Ray Tubbs Memorial Keynote Lecture
 8:10 am Keynote: Cross Talk Among Cancer Cells 

Guido Kroemer, MD, PhD (invited)
University of Paris Descartes
Paris, France
Session 4
Translational Medicine

 8:50 am Session Introduction
 8:55 am Gut Microbiome: Cancer, Immunity and Cancer Immunotherapy
Jennifer Wargo, MD, MMSc (invited)
MDAnderson Cancer Center
Houston, Texas
 9:15 am Unravelling the Role of the Microbiome in Colorectal Cancer

Phil Quirke, MD, PhD (invited)
Leeds Institute of Cancer and Pathology Leeds, United Kingdom
 9:35 am Panel Discussion | Q&A | Session Close
  
 9:55 am Break
 
Session 5
Tumor Heterogeneity and Cancer Evolution 
10:10 am Session Introduction
10:15 am
Presentation title to be announced
Charles Swanton, MD, PhD (invited)
The Francis Crick Institute

London, United Kingdom
10:35 am
Bioinformatic Dissection of Cancer Genomic Heterogeneity
Nicholas McGranahan, PhD (invited)
University College of London
London, United Kingdom
10:55 am Therapeutic Resistance to Checkpoint Blockade
Dan Landau, MD, PhD (confirmed)
Weill Cornell Medicine/New York Genome Center
New York, New York
11:15 am Panel Discussion | Q&A | Session Close
  
11:45 pm Lunch
 
Session 6
Hot Topics in Surgical Pathology
 1:00 pm Session Introduction
 1:05 pm
Pathology in the Post TGCA World
 Jorge Reis-Filho, MD, PhD (invited) Memorial Sloan Kettering Cancer Center New York, New York
 1:25 pm
Presentation title to be announced
 Speaker to be invited
 1:45 pm
Panel Discussion | Q&A | Session Close
Session 7
Immunology

 2:05 pm
Session Introduction
 2:10 pm
Presentation title to be announced
 Speaker to be invited
 2:30 pm Presentation title to be announced

Speaker to be invited
  
 2:50 pm Break
  
 3:05 pm
Immunomodulation and Vaccines for Tumor Prevention
 Olivera Finn, PhD (invited)
University of Pittsburgh Pittsburgh, Pennsylvania
 3:25 pm
Standardized Biomarkers and treatment Response to Advance New Immunotherapy Treatments that Harness the Immune System to Attack Cancer 
 Stacey Adam, PhD ​(invited)
Foundation for the National Institutes of Health
Bethesda, Maryland
 3:45 pm Panel Discussion | Q&A | Session Close
 4:15 pm Tucson Symposium 2019 Closing
 4:30 pm Symposium Adjourns

Daruka Mahadevan, MD, PhD
The University of Arizona Cancer Center
United States (Arizona)
Daruka Mahadevan, MD, PhD
The University of Arizona Cancer Center
United States (Arizona)

The Gut Microbiota to PD-1 Response/Resistance in Lung and Renal Cell Cancers

Cancer Microbiota and Host Response

Charles Swanton, MD, PhD (tentative)
The Francis Crick Institute
United Kingdom (London)

Keith Kerr
Aberdeen University Medical School
Scotland, UK
Keith Kerr
Aberdeen University Medical School
Scotland, UK
Keith Kerr
Aberdeen University Medical School
Scotland, UK
Christian Jobin, PhD
University of Florida College of Medicine
United States (Florida) 
Christian Jobin, PhD
University of Florida College of Medicine
United States (Florida) 
Christian Jobin, PhD
University of Florida College of Medicine
United States (Florida) 

Thierry Andre, MD (invited)
Hôpital Saint-Antoine
Paris, France
Andrew Beck, MD, PhD (invited)
PathAI
Cambridge, Massachusetts
Andrew Beck, MD, PhD (invited)
PathAI
Cambridge, Massachusetts

Top